Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong

Name: Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong
Published: 2007
License: Public Domain

Keryx Biopharmaceuticals · 2007

ClinicalTrials.gov · Datasets · License: Public Domain · 2007

Open Source ↗

diabetes diabetic-nephropathy

diabetic nephropathy, diabetes, microalbuminuria, proteinuria, albuminuria, krx-101, sulodexide, nephropathy, keryx, collaborative study group, diabetic nephropathy with persistent microalbuminuria, interventional

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong

Related documents